Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY20 results · Oct–Dec 2019
Divi's Laboratories reported revenue from operations of ₹1,396.26 crore and net profit of ₹359.09 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,396.26 | — | — | 1,445.57 | −3.4% |
| Other income | 41.67 | — | — | 47.03 | −11.4% |
| Total income | 1,437.93 | — | — | 1,492.60 | −3.7% |
| Profit before tax | 487.32 | — | — | 487.87 | −0.1% |
| Net profit for the period | 359.09 | — | — | 356.78 | +0.6% |
| EPS, basic (₹) | 13.53 | — | — | 13.44 | +0.7% |
| Net margin (%) | 25.7 | — | 24.7 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,390.49 | 1,342.92 | +3.5% | 1,403.92 | −1.0% |
| Other income | 40.31 | 34.56 | +16.6% | 47.36 | −14.9% |
| Total income | 1,430.80 | 1,377.48 | +3.9% | 1,451.28 | −1.4% |
| Profit before tax | 488.94 | 512.89 | −4.7% | 483.02 | +1.2% |
| Net profit for the period | 360.73 | 379.49 | −4.9% | 352.83 | +2.2% |
| EPS, basic (₹) | 13.59 | 14.29 | −4.9% | 13.29 | +2.3% |
| Net margin (%) | 25.9 | 28.3 | 25.1 |
Consolidated
- Filed with BSE
- 06 Feb 2020, 09:25 IST
- Board meeting
- 05 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Feb 2020, 09:25 IST
- Board meeting
- 05 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE